Gefitinib Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gefitinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) genes, and did not receive cancer medicines in the past. Your doctor will perform a test before you take this medicine.Gefitinib Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gefitinib Nitroso CAS NO:NA chemically represented as N-(3-Chloro-4-fluorophenyl)-N-(7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Gefitinib Nitroso . We supply Gefitinib Nitroso with detailed characterization data compliance with regulatory guidelines.